Nautilus Biotechnology Stock Forecast

Sell candidate since Jun 05, 2026 Loss -25.10%

The Nautilus Biotechnology, Inc. stock price fell by -10.50% on the last day (Monday, 29th Jun 2026) from $2.00 to $1.79. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 21.05% from a day low at $1.71 to a day high of $2.07. The price has risen in 6 of the last 10 days but is still down by -20.09% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 million shares and in total, 2 million shares were bought and sold for approximately $3.75 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -32.00% during the next 3 months and, with a 90% probability hold a price between $1.19 and $1.65 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NAUT Signals & Forecast

There are few to no technical positive signals at the moment. The Nautilus Biotechnology, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.19 and $2.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -35.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Nautilus Biotechnology, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.360 between high and low, or 21.05%. For the last week, the stock has had daily average volatility of 12.26%.

Nautilus Biotechnology, Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NAUT) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Nautilus Biotechnology, Inc. to open at $1.86, and during the day (based on 14 day Average True Range), to move between $1.69 and $1.89, which gives a possible trading interval of +/-$0.195 (+/-11.50%) up or down from last closing price. If Nautilus Biotechnology, Inc. takes out the full calculated possible swing range there will be an estimated 11.50% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.00, some $0.210 (11.73%) from the current price of $1.79, our system finds the risk reward not very attractive.

Is Nautilus Biotechnology, Inc. stock A Buy?

Nautilus Biotechnology, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.828 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 30, 2026 - $1.86 ( 3.72%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk